Here are relevant reports on : organ-on-chip-market
-
Organ-on-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose & Region - Global Forecast to 2029
The global organ-on-chip market, valued at US$89,202 thousand in 2023, stood at US$123,285 thousand in 2024 and is projected to advance at a resilient CAGR of 38.6% from 2024 to 2029, culminating in a forecasted valuation of US$631,073 thousand by the end of the period Growth in this market can mainly be attributed to the increasing government initiatives to reduce drug testing on animal models.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Organ Preservation Market by Solution Type (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2030
The global organ preservation market, valued at US$0.1 billion in 2024, stood at US$0.2 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The organ preservation market is experiencing robust growth fueled by rising incidence of chronic diseases, organ failure, and advancements in transplantation procedures.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Chip Implants for Non-Medical Applications Market, Global Forecast & Analysis (2011 - 2016)
The first implant industry has come a long way since the first heart pacemaker. There are various such other devices such as drug infusion pumps which would have been imposible without the development of sophisticated sensors on a chip and the miniaturization of mechanical parts.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)
The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
Global Chip on Board (COB) Light Emitting Diode Market (2011-2016)
Urbanization, increasing infrastructure, and government initiatives are the factors resulting into increase in modern lighting products. Incandescent lighting turns out to be a very costly and poor medium of lighting source. This stirs the push to LED lighting. COB LED technology has emerged due to its features such as low power consumption, cost effective lighting, and high intensity output. COB LED market contributes around 7 to 8% to the overall market for LED and is expected to reach around 20% in the near future.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
Global Chip Based Acoustic Instrument Market 2011 – 2016
Acoustic musical instrument produces sound, the loudness and spectral content of the sound change over time in ways that vary from instrument to instrument. The attack and decay of a sound have a great effect on the instrument's sonic character
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
POP Treatment and Management / Pelvic Organ Prolapse Market by Product (Synthetic Mesh, Sutures, Pessaries, Robotic Systems), Treatment (Surgical, PFMT), Application (Cystocele, Uterine Prolapse), End User (Hospitals, ASCs), Region - Global Forecast to 2030
The global POP Treatment and Management / Pelvic Organ Prolapse market, valued at US$0.72 billion in 2024, stood at US$0.77 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$1.06 billion by the end of the period. The POP Treatment and Management / Pelvic Organ Prolapse market is primarily driven by the rising prevalence of pelvic floor disorders, particularly among aging women, and increased awareness of available treatment options.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Gynaecology Equipment Market by Product (Gynecology Endoscopy, Endometrial Ablation, Fluid Management, Female Sterilization), Disease Type (Pelvic Organ Prolapse, Fetal Monitoring, Breast, Cervical, Endometrial), and End User - Global Forecast to 2023
The global gynecology equipment market is expected to reach USD 668.2 million by 2023 from USD 521.1 million in 2018, growing at a CAGR of 5.1%. Increasing gynecological procedures; increasing incidence of gynecological disorders; technological advancements and research in field of gynecological; are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User and Region - Global Forecast to 2030
The global urology devices market is expected to grow from USD 34.56 billion in 2025 to USD 46.26 billion by 2030, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.The Key Players Fresenius Medical Care AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Autotransfusion Systems Market by Type (Autotransfusion Products & Accessories) and Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures) - Global Forecast to 2024
The Autotransfusion Systems Market is expected to grow from USD 395 million in 2019 to USD 505 million by 2024, at a CAGR of 5.0% during the forecast period. Becton, Dickinson and Company (US), Zimmer Biomet Holdings, Inc. (US), Teleflex Incorporated (US), and Haemonetics Corporation (US) are some of the major players operating in the North American market.
- Published: August 2019
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
